These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7509011)

  • 1. [Development of hepatocellular carcinoma in the patients with a history of tuberculosis].
    Sugiura N; Saisho H; Shimura A
    Kekkaku; 1994 Jan; 69(1):1-5. PubMed ID: 7509011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
    Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma and its risk factors--their annual changes and effects on the age at onset.
    Yamaguchi G
    Kurume Med J; 1993; 40(1):33-40. PubMed ID: 8394954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-B hepatocellular carcinoma: influence of age, sex, alcohol, family clustering, blood transfusion and chronic liver disease.
    Yamada G; Mizuno M; Kinoyama S; Nishihara T; Okushin H; Hyodo I; Sakamoto Y; Nagashima H
    Acta Med Okayama; 1984 Apr; 38(2):181-91. PubMed ID: 6328894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased incidence of hepatocellular carcinoma].
    Wawrzynowicz-Syczewska M; Leonciuk A; Jurczyk K; Karpińska E; Boroń-Kaczmarska A
    Pol Merkur Lekarski; 2002 Aug; 13(74):100-2. PubMed ID: 12420336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of prognostic factors in hepatocellular carcinoma in Japan.
    Nouso K; Kobayashi Y; Nakamura S; Kobayashi S; Toshimori J; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K
    Aliment Pharmacol Ther; 2010 Feb; 31(3):407-14. PubMed ID: 19849688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and follow-up of the high risk group for hepatocellular carcinoma].
    Araki E
    Gan No Rinsho; 1984 Sep; 30(11):1373-8. PubMed ID: 6094881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
    Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center.
    Abdel-Wahab M; El-Ghawalby N; Mostafa M; Sultan A; El-Sadany M; Fathy O; Salah T; Ezzat F
    Hepatogastroenterology; 2007; 54(73):157-62. PubMed ID: 17419252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and pathological features of hepatocellular carcinoma in Nnewi, Nigeria.
    Okonkwo UC; Nwosu MN; Ukah C; Okpala OC; Ahaneku JI
    Niger J Med; 2011; 20(3):366-71. PubMed ID: 21970220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.
    Takano S; Yokosuka O; Imazeki F; Tagawa M; Omata M
    Hepatology; 1995 Mar; 21(3):650-5. PubMed ID: 7875662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
    Yu ZY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.
    Ayoola EA; Gadour MO
    J Gastroenterol Hepatol; 2004 Jun; 19(6):665-9. PubMed ID: 15151622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
    Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
    J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in chronic liver disease in Natal.
    Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
    S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of hepatocellular carcinoma incidence in thalassemia.
    Mancuso A; Sciarrino E; Renda MC; Maggio A
    Hemoglobin; 2006; 30(1):119-24. PubMed ID: 16540424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of patients with hepatocellular carcinoma with non-A, non-B hepatitis virus].
    Takezaki E; Maeda Y; Fukuda K; Kagawa K; Omori H
    Gan No Rinsho; 1989 Jun; 35(7):781-6. PubMed ID: 2544748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.